Biological therapy for ocular Behçet's disease with off-label drug prescription in Turkey.

Mehmet ÇıtırıkCemile Ucgul AtilganHanife RahmanlarAli AlkanHakki Gursoz

Published in: European journal of hospital pharmacy : science and practice (2021)

IFX and ADA are rarely used as initial therapy. Stepwise treatment is still preferred in the treatment of ocular Behçet's disease in Turkey. Our report informs on the management of this difficult-to-treat condition.

Keyphrases

stem cells
combination therapy
mesenchymal stem cells
adverse drug